Document:

Exhibit
10.4

 

PRIVATE
PLACEMENT WARRANTS PURCHASE AGREEMENT

 

THIS
PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this
“Agreement”), dated as of November 23, 2021, is entered into by and between InFinT Acquisition Corporation, a Cayman Islands
exempted company (the “Company”), and InFinT Capital LLC, a Delaware limited liability company (the “Purchaser”).

 

WHEREAS,
the Company intends to consummate an initial public offering of the Company’s units (the “Public Offering”), each unit
consisting of one Class A ordinary share of the Company, par value $0.0001 per share (each, a “Share”), and one-half of one
redeemable warrant, each whole warrant entitling the holder to purchase one Share at an exercise price of $11.50 per Share, as set forth
in the Company’s Registration Statement on Form S-1, filed with the U.S. Securities and Exchange Commission (the “SEC”),
File Number 333-256310, under the Securities Act of 1933, as amended (the “Securities Act”).

 

WHEREAS,
the Purchaser has agreed to purchase an aggregate of 7,032,580 warrants (and up to 764,262 additional redeemable warrants if the underwriters
in the Public Offering exercise their option to purchase additional units in full) (the “Private Placement Warrants”), each
Private Placement Warrant entitling the holder to purchase one Share at an exercise price of $11.50 per Share, at a price of $1.00 per
warrant, subject to adjustment.

 

NOW
THEREFORE, in consideration of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section
1. Authorization, Purchase and Sale; Terms of the Private Placement Warrants.

 

A.
Authorization of the Private Placement Warrants. The Company has duly authorized the issuance and sale of the Private Placement
Warrants to the Purchaser.

 

		B.	Purchase
                                            and Sale of the Private Placement Warrants.

 

(i)
On the date of the consummation of the Public Offering
(the “IPO Closing Date”), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company,
7,032,580 Private Placement Warrants at a price of $1.00 per warrant for an aggregate purchase price of $7,032,580 (the “Purchase
Price”). The Purchaser shall pay the Purchase Price by wire transfer of immediately available funds in the following amounts: (i)
$[0] to the Company at a financial institution to be chosen by the Company, and (ii) $7,032,580 to the trust account maintained by Continental
Stock Transfer & Trust Company, acting as trustee (the “Trust Account”), in each case in accordance with the Company’s
wiring instructions, at least one (1) business day prior to the IPO Closing Date. On the IPO Closing Date, subject to the receipt of
funds pursuant to the immediately prior sentence, the Company, at its option, shall deliver a certificate evidencing the Private Placement
Warrants purchased on such date duly registered in the Purchaser’s name to the Purchaser or effect such delivery in book-entry
form.

 

(ii)
On the date of the closing of the option to purchase
additional units, if any, in connection with the Public Offering or on such earlier time and date as may be mutually agreed by the Purchaser
and the Company (the “Option Closing Date”, and each Option Closing Date (if any) and the IPO Closing Date, a “Closing
Date”), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, up to 764,262 Private
Placement Warrants (or, to the extent the option to purchase additional units is not exercised in full, a lesser number of Private Placement
Warrants in proportion to portion of the option that is exercised) at a price of $1.00 per warrant for an aggregate purchase price of
up to $764,262 (the “Option Purchase Price”). The Purchaser shall pay the Option Purchase Price in accordance with the Company’s
wire instruction by wire transfer of immediately available funds to the Trust Account, at least one (1) business day prior to the Option
Closing Date. On the Option Closing Date, subject to the receipt of funds pursuant to the immediately prior sentence, the Company shall,
at its option, deliver a certificate evidencing the Private Placement Warrants purchased on such date duly registered in the Purchaser’s
name to the Purchaser or effect such delivery in book-entry form.

 

    	 

     

    

 

		C.	Terms
                                            of the Private Placement Warrants.

 

(i)
Each Private Placement Warrant shall have the terms
set forth in a Warrant Agreement to be entered into by the Company and a warrant agent on the IPO Closing Date, in connection with the
Public Offering (the “Warrant Agreement”).

 

(ii)
On the IPO Closing Date, the Company and the Purchaser
shall enter into a registration and shareholder rights agreement (the “Registration and Shareholder Rights Agreement”) pursuant
to which the Company will grant certain registration rights to the Purchaser relating to the Private Placement Warrants and the Shares
underlying the Private Placement Warrants.

 

D.
The total number of shares of all classes of capital stock which the Company has authority to issue is 550,000,000 ordinary shares (which
consist of 500,000,000 shares of the Company’s Class A ordinary shares and 50,000,000 shares of the Company’s Class B ordinary
shares, par value $0.0001 per share (the “Class B Common Stock”)) and 5,000,000 shares of the Company’s preference
shares, par value $0.0001 per share (the “Preferred Stock”). As of the date hereof, the Company has issued and outstanding
no shares of Class A Common Stock, 5,833,083 shares of Class B Common Stock (of which up to 760,837 shares are subject to forfeiture
as described in the Registration Statement) and no shares of Preferred Stock. All of the issued shares of capital stock of the Company
have been duly authorized, validly issued, and are fully paid and non-assessable.

 

Section
2. Representations and Warranties of the Company.

 

As
a material inducement to the Purchaser to enter into this Agreement and purchase the Private Placement Warrants, the Company hereby represents
and warrants to the Purchaser (which representations and warranties shall survive each Closing Date) that:

 

A.
Incorporation and Corporate Power. The Company is an exempted company duly incorporated, validly existing and in good standing
under the laws of the Cayman Islands and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably
be expected to have a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses
all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.

 

		B.	Authorization;
                                            No Breach.

 

(i)
The execution, delivery and performance of this Agreement
and the Private Placement Warrants have been duly authorized by the Company as of the Closing Date. This Agreement constitutes the valid
and binding obligation of the Company, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent conveyance,
reorganization, moratorium and other laws of general applicability relating to or affecting creditors’ rights and to general equitable
principles (whether considered in a proceeding in equity or law). Upon issuance in accordance with, and payment pursuant to, the terms
of the Warrant Agreement and this Agreement, the Private Placement Warrants will constitute valid and binding obligations of the Company,
enforceable in accordance with their terms as of the Closing Date.

 

(ii)
The execution and delivery by the Company of this Agreement
and the Private Placement Warrants, the issuance and sale of the Private Placement Warrants, the issuance of the Shares upon exercise
of the Private Placement Warrants and the fulfillment of and compliance with the respective terms hereof and thereof by the Company,
do not and will not as of the Closing Date (a) conflict with or result in a breach of the terms, conditions or provisions of, (b) constitute
a default under, (c) result in the creation of any lien, security interest, charge or encumbrance upon the Company’s share capital
or assets under, (d) result in a violation of, or (e) require any authorization, consent, approval, exemption or other action by or notice
or declaration to, or filing with, any court or administrative or governmental body or agency pursuant to the memorandum and articles
of association of the Company (in effect on the date hereof or as may be amended prior to completion of the Public Offering) or any material
law, statute, rule or regulation to which the Company is subject, or any agreement, order, judgment or decree to which the Company is
subject, except for any filings required after the date hereof under federal or state securities laws.

 

    	 

     

    

 

C.
Title to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, and
upon registration in the Company’s register of members, the Shares issuable upon exercise of the Private Placement Warrants will
be duly and validly issued, fully paid and nonassessable. On the date of issuance of the Private Placement Warrants, the Shares issuable
upon exercise of the Private Placement Warrants shall have been reserved for issuance. Upon issuance in accordance with, and payment
pursuant to, the terms hereof and the Warrant Agreement, and upon registration in the Company’s register of members, the Purchaser
will have good title to the Private Placement Warrants purchased by it and the Shares issuable upon exercise of such Private Placement
Warrants, free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions hereunder and under
the other agreements contemplated hereby, (ii) transfer restrictions under federal and state securities laws, and (iii) liens, claims
or encumbrances imposed due to the actions of the Purchaser.

 

D.
Governmental Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority
is required in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company
of any other transactions contemplated hereby.

 

E.
Regulation D Qualification. Neither the Company nor, to its actual knowledge, any of its affiliates, members, officers, directors
or beneficial shareholders of 20% or more of its outstanding securities, has experienced a disqualifying event as enumerated pursuant
to Rule 506(d) of Regulation D under the Securities Act.

 

Section
3. Representations and Warranties of the Purchaser.

 

As
a material inducement to the Company to enter into this Agreement and issue and sell the Private Placement Warrants to the Purchaser,
the Purchaser hereby represents and warrants to the Company (which representations and warranties shall survive each Closing Date) that:

 

A.
Organization and Requisite Authority. The Purchaser possesses all requisite power and authority necessary to carry out the transactions
contemplated by this Agreement.

 

		B.	Authorization;
                                            No Breach.

 

(i)
This Agreement constitutes a valid and binding obligation
of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium and other laws of general applicability relating to or affecting creditors’ rights and to general equitable principles
(whether considered in a proceeding in equity or law).

 

(ii)
The execution and delivery by the Purchaser of this
Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser does not and shall not as of each Closing Date
(a) conflict with or result in a breach by the Purchaser of the terms, conditions or provisions of, (b) constitute a default under, (c)
result in the creation of any lien, security interest, charge or encumbrance upon the Purchaser’s equity or assets under, (d) result
in a violation of, or (e) require authorization, consent, approval, exemption or other action by or notice or declaration to, or filing
with, any court or administrative or governmental body or agency pursuant to the Purchaser’s organizational documents in effect
on the date hereof or as may be amended prior to completion of the contemplated Public Offering, or any material law, statute, rule or
regulation to which the Purchaser is subject, or any agreement, instrument, order, judgment or decree to which the Purchaser is subject,
except for any filings required after the date hereof under federal or state securities laws.

 

		C.	Investment
                                            Representations.

 

(i)
The Purchaser is acquiring the Private Placement Warrants
and, upon exercise of the Private Placement Warrants, the Shares issuable upon such exercise (collectively, the “Securities”)
for its own account, for investment purposes only and not with a view towards, or for resale in connection with, any public sale or distribution
thereof.

 

    	 

     

    

 

(ii)
The Purchaser is an “accredited investor”
as such term is defined in Rule 501(a)(3) of Regulation D, and the Purchaser has not experienced a disqualifying event as enumerated
pursuant to Rule 506(d) of Regulation D under the Securities Act.

 

(iii)
The Purchaser understands that the Securities are being
offered and will be sold to it in reliance on specific exemptions from the registration requirements of the United States federal and
state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchaser’s compliance with, the
representations and warranties of the Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility
of the Purchaser to acquire such Securities.

 

(iv)
The Purchaser did not decide to enter into this Agreement
as a result of any general solicitation or general advertising within the meaning of Rule 502(c) under the Securities Act.

 

(v)
The Purchaser has been furnished with all materials
relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities which
have been requested by the Purchaser. The Purchaser has been afforded the opportunity to ask questions of the executive officers and
directors of the Company. The Purchaser understands that its investment in the Securities involves a high degree of risk and it has sought
such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to the acquisition
of the Securities.

 

(vi)
The Purchaser understands that no United States federal
or state agency or any other government or governmental agency has passed on or made any recommendation or endorsement of the Securities
or the fairness or suitability of the investment in the Securities by the Purchaser nor have such authorities passed upon or endorsed
the merits of the offering of the Securities.

 

(vii)
The Purchaser understands that: (a) the Securities have
not been and are not being registered under the Securities Act or any state securities laws, and may not be offered for sale, sold, assigned
or transferred unless (1) subsequently registered thereunder or (2) sold in reliance on an exemption therefrom; and (b) except as specifically
set forth in the Registration and Shareholder Rights Agreement, neither the Company nor any other person is under any obligation to register
the Securities under the Securities Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder;
and (c) Rule 144 adopted pursuant to the Securities Act will not be available for resale transactions of Securities prior to a Business
Combination and may not be available for resale transactions of Securities after a Business Combination.

 

(viii)
The Purchaser has such knowledge and experience in financial
and business matters, knowledge of the high degree of risk associated with investments in the securities of companies in the development
stage such as the Company, is capable of evaluating the merits and risks of an investment in the Securities and is able to bear the economic
risk of an investment in the Securities in the amount contemplated hereunder for an indefinite period of time. The Purchaser has adequate
means of providing for its current financial needs and contingencies and will have no current or anticipated future needs for liquidity
which would be jeopardized by the investment in the Securities. The Purchaser can afford a complete loss of its investments in the Securities.

 

(ix)
The Purchaser understands that the Private Placement
Warrants shall bear the legend substantially in the form set forth in the Warrant Agreement.

 

Section
4. Conditions of the Purchaser’s Obligations. The obligations of the Purchaser to purchase and pay for the Private Placement
Warrants are subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

 

A.
Representations and Warranties. The representations and warranties of the Company contained in Section 2 shall be true and correct
at and as of the Closing Date as though then made.

 

    	 

     

    

 

B.
Performance. The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement
that are required to be performed or complied with by it on or before such Closing Date.

 

C.
No Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization
having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this
Agreement or the Warrant Agreement.

 

D.
Warrant Agreement and Registration and Shareholder Rights Agreement. The Company shall have entered into the Warrant Agreement,
substantially in the form of Exhibit A hereto, and the Registration and Shareholder Rights Agreement, substantially in the form of Exhibit
B hereto, in each case on terms satisfactory to the Purchaser.

 

Section
5. Conditions of the Company’s Obligations. The obligations of the Company to the Purchaser under this Agreement are subject
to the fulfillment, on or before each Closing Date, of each of the following conditions:

 

A.
Representations and Warranties. The representations and warranties of the Purchaser contained in Section 3 shall be true and correct
at and as of such Closing Date as though then made.

 

B.
Performance. The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this
Agreement that are required to be performed or complied with by the Purchaser on or before such Closing Date.

 

C.
Corporate Consents. The Company shall have obtained the consent of its Board of Directors authorizing the execution, delivery
and performance of this Agreement and the Warrant Agreement and the issuance and sale of the Private Placement Warrants hereunder.

 

D.
No Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization
having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this
Agreement or the Warrant Agreement.

 

		E.	Warrant
                                            Agreement. The Company shall have entered into the Warrant Agreement.

 

Section
6. Miscellaneous.

 

A.
Successors and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement
by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether
so expressed or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement, other
than assignments by the Purchaser to affiliates thereof (including, without limitation one or more of its members).

 

B.
Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision
shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

C.
Counterparts. This Agreement may be executed simultaneously in two or more counterparts, none of which need contain the signatures
of more than one party, but all such counterparts taken together shall constitute one and the same agreement. Signatures to this Agreement
transmitted via facsimile or e-mail shall be valid and effective to bind the party so signing.

 

    	 

     

    

 

D.
Descriptive Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not
constitute a substantive part of this Agreement. The use of the word “including” in this Agreement shall be by way of example
rather than by limitation.

 

E.
Governing Law. This Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes
shall be construed in accordance with the internal laws of the State of New York, without giving effect to conflicts of law principles
that would result in the application of the laws of another jurisdiction.

 

F.
Amendments. This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument
executed by the parties hereto.

 

[Signature
page follows]

 

    	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement.

 

	 	COMPANY:
	 	 
	 	INFINT
  ACQUISITION CORPORATION
	 	 	 
	 	By:	/s/
  Sheldon Brickman
	 	Name:	Sheldon
  Brickman
	 	Title:	Chief
  Financial Officer

 

	 	PURCHASER:
	 	 
	 	INFINT
    CAPITAL LLC
	 	 	 
	 	By:	/s/
    Alexander Edgarov
	 	Name:	Alexander
    Edgarov
	 	Title:	Manager

 

Signature
Page to Private Placement Warrant Purchase Agreement

 

    	 

     

    

 

EXHIBIT
A

Warrant
Agreement

 

    	 

     

    

 

EXHIBIT
B

Registration
and Shareholder Rights AgreementExhibit 10.5

 

November
23, 2021

 

EF
Hutton, division of Benchmark Investments, LLC

590
Madison Avenue, 39th Floor

New
York, NY 10022

 

Re:
Transfer of Founder Shares as Representative Shares

 

Ladies
and Gentlemen:

 

This
transfer agreement (this “Agreement”) is being delivered to you in accordance with and pursuant to the Underwriting Agreement
(the “Underwriting Agreement”) entered into by and among InFinT Acquisition Corporation, a Cayman Islands exempted company
(the “Company”), EF Hutton, division of Benchmark Investments, LLC (previously known as Kingswood Capital Markets, division
of Benchmark Investments, LLC) (the “Representative”) of the underwriters (the “Underwriters”), relating to an
underwritten initial public offering (the “Public Offering”) of up to 19,999,880 of the Company’s units, including
up to 2,608,680 units that may be purchased pursuant to the Underwriters’ option to purchase additional units (the “Over-Allotment
Option”), each comprised of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Ordinary
Shares”), and one-half of one redeemable warrant (each whole warrant, a “Warrant”) (the “Units”). Each
Warrant entitles the holder thereof to purchase one Ordinary Share at a price of $11.50 per share, subject to adjustment. The Units will
be sold in the Public Offering pursuant to a registration statement on Form S-1 and a prospectus (the “Prospectus”) as filed
by the Company with the U.S. Securities and Exchange Commission.

 

In
order to induce the Underwriters to enter into the Underwriting Agreement and to proceed with the Public Offering and for other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, InFinT Capital LLC, (the “Sponsor”),
the Company and the Representative hereby agree as follows:

 

1.
Transfer of Founder Shares.

 

(a)
The Sponsor hereby agrees to assign, transfer and convey to the Representative (and/or its designees) an aggregate of 60,869 Class B
ordinary shares of the Company, par value $0.0001 per share (“Founder Shares”), or up to 69,999 Founder Shares if the Over-Allotment
Option is exercised in full) to the Representative (the “Representative’s Shares”) on the terms and conditions set
forth herein. The Company and the Representative intend for the Representative Shares to be underwriter’s compensation pursuant
to Rule 5110 of the FINRA Manual.

 

(b)
Delivery for 69,999 Representative’s Shares shall be made on the closing date of the Underwriting Agreement. On such date, the
Sponsor shall deliver to the Representative or its designees, such Representative’s Shares, and the Company will facilitate such
transfer with its transfer agent so that such Representative’s Shares are delivered in book-entry form in the name or names and
in such authorized denominations as the Representative may request.

 

(c)
Partial or No Exercise of the Over-allotment Option. In the event the Over-allotment Option granted to the Underwriters is not
exercised in full, the Representative acknowledges and agrees that it shall immediately assign, transfer and convey back to Sponsor any
and all rights to such number of Representative’s Shares (up to an aggregate of 9,130 Representative’s Shares and pro rata
based upon the percentage of the Over-allotment Option exercised) such that immediately following such assignment, transfer and conveyance,
the Representative will own an aggregate number of Founder Shares (not including class A ordinary shares purchased by Representative
in the IPO or in the aftermarket) equal to 0.35% (i.e., 70% of the 0.5%) of the gross proceeds of the Public Offering at $10.00 per share.

 

(d)
Termination of Rights. If any of the Representative’s Shares are assigned, transferred and conveyed back to Sponsor in accordance
with this Section 2, then after such time the Representative (or successor in interest), shall no longer have any rights as a holder
of such Representative’s Shares, and the Company shall take such action as is appropriate to facilitate the transfer back to Sponsor
of such shares.

 

    	 

     

    

 

2.
Representations and Warranties of Sponsor.

 

(a)
Sponsor is the legal and owner of record of the Founder Shares. Sponsor has good and valid title to the Founder Shares, free and clear
of all liens, encumbrances, charges, agreements, warrants, options, claims, rights and interests of all others whomsoever, except restrictions
under applicable securities laws, except as otherwise disclosed in the Prospectus. Upon assignment, transfer and conveyance hereunder,
the Representative will acquire good and valid title to the Representative’s Shares and will be the absolute legal and beneficial
owner of the Representative’s Shares, free and clear of all liens, encumbrances, charges, agreements, warrants, options, claims,
rights and interests of all others whomsoever, except restrictions under applicable securities laws and as disclosed in the Prospectus.

 

(b)
Sponsor has full right, power and authority (i) to execute and deliver this Agreement, (ii) to perform its obligations under this Agreement
and (iii) to transfer, assign and convey and deliver to Purchaser good and valid title to the Representative’s Shares pursuant
to this Agreement. Neither the execution, nor the carrying out of the terms of this Agreement will constitute a breach or default of
any agreement, indenture, trust, will or other obligation to which Sponsor is a party or otherwise bound.

 

(c)
Sponsor acknowledges that this Agreement and the terms contained herein are binding and enforceable against Sponsor, and that the Representative
and/or the Company shall be entitled to damages for any breach of the Representations and Warranties contained in this S ection 3.

 

3.
Representations and Warranties of Representative. The Representative represents and warrants to the Company and the Sponsor that
it has full right, power and authority (i) to execute and deliver this Agreement and (ii) to perform its obligations under this Agreement.
Neither the execution, nor the carrying out of the terms of this Agreement will constitute a breach or default of any agreement, indenture,
trust, will or other obligation to which the Representative is a party or otherwise bound. The Representative acknowledges that this
Agreement and the terms contained herein are binding and enforceable against the Representative, and that the Sponsor and/or the Company
shall be entitled to damages for any breach of the Representations and Warranties contained in this Section 4.

 

4.
Representations and Warranties of the Company. The Company represents and warrants to the Representative and the Sponsor that
it has full right, power and authority (i) to execute and deliver this Agreement and (ii) to perform its obligations under this Agreement.
Neither the execution, nor the carrying out of the terms of this Agreement will constitute a breach or default of any agreement, indenture,
trust, will or other obligation to which the Company is a party or otherwise bound. The Company acknowledges that this Agreement and
the terms contained herein are binding and enforceable against the Company, and that the Sponsor and/or the Representative shall be entitled
to damages for any breach of the Representations and Warranties contained in this Section 5.

 

5.
Remedies. Each party hereto hereby agrees and acknowledges that the other parties hereto would each be irreparably injured in
the event of a breach by a party of its obligations hereunder, (ii) monetary damages may not be an adequate remedy for such breach and
(iii) the non-breaching party shall be entitled to injunctive relief, in addition to any other remedy that such party may have in law
or in equity, in the event of such breach.

 

6.
Disclaimer. Except for the representations and warranties expressly and specifically made by Sponsor herein, (1) the Representative
acknowledges and agrees that, in making its determination to proceed hereunder, that Sponsor is not making or has not made, and specifically
disclaims, any representation or warranty, expressed or implied, at law or in equity, in respect of the Company, any subsidiaries or
any entity in which the Company owns any equity interest, or their respective businesses, assets, liabilities, operations, results of
operations, prospects, or future or historical condition (financial or otherwise), including, without limitation with respect to merchantability
or fitness for any particular purpose of any assets, the nature or extent of any liabilities, the prospects of its business, the effectiveness
or the success of any operations, or the accuracy or completeness of any confidential information memoranda, documents, projections,
material or other information (financial or otherwise) regarding any of the aforementioned entities, or in respect of any other matter
or thing whatsoever; (2) the Representative specifically disclaims that it is relying upon or has relied upon any such other representations
or warranties that may have been made by any person, and acknowledges and agrees that Sponsor has specifically disclaimed and does hereby
specifically disclaim any such other representation or warranty made by any person; (3) the Representative specifically disclaims any
obligation or duty to make any disclosures of fact not required to be disclosed pursuant to the specific representations and warranties
set forth herein; (4) the Representative is acquiring the Representative’s Shares subject only to the specific representations
and warranties set forth herein; and (5) the Representative has conducted to its satisfaction an independent investigation of the financial
condition, operations, assets, liabilities and properties of the Company and the other entities contemplated hereinabove, including,
without limitation, a review of the Prospectus.

 

    	 

     

    

 

7.
Entire Agreement. This Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject
matter hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral,
to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Agreement may not be
changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written
instrument executed by all parties hereto.

 

8.
Assignment. No party hereto may assign either this Agreement or any of its rights, interests, or obligations hereunder without
the prior written consent of the other parties. Any purported assignment in violation of this paragraph shall be void and ineffectual
and shall not operate to transfer or assign any interest or title to the purported assignee. This Agreement shall be binding on each
party hereto each of its respective successors, heirs, personal representatives and assigns and permitted transferees.

 

9.
Counterparts. This Agreement may be executed in any number of original or facsimile counterparts, and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

10.
Effect of Headings. The paragraph headings herein are for convenience only and are not part of this Agreement and shall not affect
the interpretation thereof.

 

11.
Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof
shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any
such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision
as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

12.
Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the Cayman Islands.
The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Agreement
shall be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit to such jurisdiction and
venue, which jurisdiction and venue shall be exclusive, and (ii) waive any objection to such exclusive jurisdiction and venue or that
such courts represent an inconvenient forum.

 

13.
Notices. Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall
be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by
hand delivery or facsimile transmission.

 

	 	Sincerely,
	 	 	 
	 	INFINT
    CAPITAL LLC
	 	 	 
	 	By:	/s/
    Alexander Edgarov
	 	Name:	Alexander
    Edgarov
	 	Title:	Managing
    Member
	 	Date:	November
    23, 2021

 

    	 

     

    

 

Acknowledged
and Agreed:

 

	EF
    Hutton, division of Benchmark Investments, LLC	 
	 	 	 
	By:	/s/
    Sam Fleischman	 
	Name:	Sam
    Fleischman	 
	Title:	Supervisory
    Principal	 
	Date:	November
    23, 2021	 
	 	 	 
	InFinT
    Acquisition Corporation	 
	 	 	 
	By:	/s/
    Sheldon Brickman	 
	Name:	Sheldon
    Brickman	 
	Title:	Chief
    Financial Officer	 
	Date:	November
    23, 2021	 

 

[Signature
Page to Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]